Brain neurotransmitter abnormalities in neuronal intranuclear inclusion body disorder

Ann Neurol. 1985 Apr;17(4):405-7. doi: 10.1002/ana.410170419.

Abstract

Biochemical markers for the major neurotransmitter systems were measured in the brain of a patient who died with neuronal intranuclear inclusion disease. A severe nigrostriatal dopamine deficiency constitutes the basis for the parkinsonian features in the patient. A marked loss of brain norepinephrine and serotonin was found in the basal ganglia and hypothalamus. Brain amino acid (gamma-aminobutyric acid and glutamate) and cholinergic (choline acetyltransferase activity) systems were either normal or less severely affected.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Brain / pathology
  • Brain Diseases / metabolism*
  • Brain Diseases / pathology
  • Dopamine / analysis
  • Female
  • Homovanillic Acid / analysis
  • Humans
  • Hydroxyindoleacetic Acid / analysis
  • Inclusion Bodies / metabolism*
  • Inclusion Bodies / pathology
  • Neurons / metabolism*
  • Neurons / pathology
  • Neurotransmitter Agents / analysis*
  • Norepinephrine / analysis
  • Serotonin / analysis
  • gamma-Aminobutyric Acid / analysis

Substances

  • Neurotransmitter Agents
  • Serotonin
  • Hydroxyindoleacetic Acid
  • gamma-Aminobutyric Acid
  • Dopamine
  • Norepinephrine
  • Homovanillic Acid